Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 4 Description of Capital Stock
- 10.32 Letter Agreement with 3I, LP Dated December 9, 2022
- 10.35 Letter Agreement with 3I, LP Dated January 23, 2023
- 21.1 Subsidiaries of the Registrant
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
ALLR similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries
Name | Jurisdiction of Incorporation | |
Allarity Acquisition Subsidiary Inc. | Delaware | |
Allarity Therapeutics Europe ApS (formerly Oncology Venture Product Development ApS)* | Denmark | |
Allarity Therapeutics Denmark ApS (formerly OV-SPV2 ApS)* | Denmark | |
Medical Prognosis Institute, Inc.*(1) | Arizona | |
Oncology Venture US Inc.*(1) | Delaware |
* | wholly-owned subsidiary of Allarity Acquisition Subsidiary, Inc |
(1) | In the process of being dissolved because inactive. |